Leading Justice is a full-service marketing company working with law firms on a cash-buy basis to sign up fully qualified, fraud-free ethylene oxide cancer cases. Here at Leading Justice, we can customize your firm’s ethylene oxide advertising needs and help you sign up cases via internal cash buys. Our clients only pay an agency fee to cover the cost of ethylene oxide cancer advertising, plus a fee for each case we sign, and any data we generate for your firm belongs to you. We also cross-qualify all our contacts, which means any data we generate that doesn’t qualify for the target campaign is reviewed to determine whether it qualifies for another type of claim. By using innovative approaches to target contacts specifically related to ethylene oxide and side effects like non-Hodgkin’s lymphoma, leukemia, myeloma and breast cancer, Leading Justice will increase your firm’s ethylene oxide exposure caseload. If you are interested in helping victims of toxic ethylene oxide exposure, our extensive consumer reach and direct advertising strategies at Leading Justice give you the competitive edge and confidence you need to allocate your full budget, with the knowledge that your money is being used in the best way possible.
Each law firm we work with at Leading Justice plays an important role in determining how we categorize claims as qualified or not. And while our experience working with plaintiff law firms allows us to recognize a great case when we see one, we will customize our ethylene oxide exposure intake specifications to the exact criteria you are seeking. So, if your firm has specific ethylene oxide exposure qualifying case criteria you want us to use, we can train our intake specialists to apply the criteria to each phone call and email they receive. By eliminating the middle man, Leading Justice offers clients an opportunity for internal cash buys of ethylene oxide cancer data with zero chance of fraud.
Ethylene Oxide Exposure Litigation
Ethylene oxide is a carcinogenic chemical commonly used to sterilize medical equipment and make a wide variety of products, including antifreeze, detergents, plastics and adhesives. Recent reports suggest that ethylene oxide fumes emitted from manufacturing plants and medical device sterilization plants, like the recently shuttered Sterigenics plant in Willowbrook, Illinois, may pose a serious risk for workers who regularly breathe in the fumes on the job and for the people who live and work in the areas surrounding these plants. The EPA has concluded that inhalation of ethylene oxide is carcinogenic to humans and exposure to the chemical has been linked to non-Hodgkin’s lymphoma, myeloma, lymphocytic leukemia and breast cancer, among other serious side effects. According to the EPA, more than 20,000 people live within one mile of the Sterigenics facility, where the cancer risk was found to be 64 times the acceptable risk limit in 2018, and where there are also four schools, a day care facility, a shopping center and a community park nearby.
Sterigenics’ Willowbrook facility is currently at the center of the ethylene oxide controversy and the company is accused of knowing for decades about the potential health risks associated with ethylene oxide exposure, yet doing nothing to protect workers or the communities in which it operates from the harmful effects of ethylene oxide exposure. But there are other medical equipment sterilization and manufacturing plants that also use ethylene oxide, including plants run by Medline Industries and Vantage Specialty Chemicals, and these companies have also found themselves facing lawsuits filed by plaintiffs alleging that exposure to ethylene oxide caused them to develop cancer and other serious illnesses. So far, more than 40 ethylene oxide exposure lawsuits have been filed in Illinois, and as more and more people in Illinois and other areas come to find that their cancers and other illnesses may have been caused by breathing in toxic ethylene oxide fumes, the ethylene oxide litigation is expected to grow.